BIO EBITDA

Bio-Rad Laboratories, Inc. Class A Common Stock · EBITDA

BIO logo

BIO EBITDA

Latest reported$514.70M
BIO TTM EBITDA ($11.80M → $514.70M)
High-resolution chart · PNG

BIO ebitda history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Bio-Rad Laboratories, Inc. Class A Common Stock EBITDA — Trailing twelve months (TTM) (USD)
Period endingEBITDA (USD)
514,700,000
439,800,000
1,209,900,000
-621,300,000
665,994,000
-2,538,823,000
-2,131,868,000
-806,515,000
-1,532,409,000
-247,076,000
-654,765,000
10,247,000
-337,908,000
-61,009,000
-4,524,359,000
-7,671,315,000
-2,453,608,000
-87,385,000
5,573,500,000
8,696,927,000
5,364,364,000
5,459,911,000
5,067,599,000
4,656,957,000
2,637,177,000
2,159,434,000
2,387,597,000
678,195,000
1,365,281,000
937,102,000
674,721,000
1,761,167,000
1,449,824,000
1,113,526,000
268,643,000
192,455,000
179,513,000
205,422,000
206,399,000
290,811,000
288,799,000
295,225,000
303,145,000
299,600,000
305,777,000
319,974,000
309,992,000
313,023,000
308,743,000
313,675,000
324,186,000
337,106,000
369,451,000
383,895,000
406,052,000
418,353,000
417,811,000
407,226,000
409,897,000
397,813,000
397,955,000
394,231,000
392,900,000
342,671,000
335,976,000
325,291,000
306,859,000
287,496,000
271,312,000
267,285,000
269,785,000
287,374,000
263,704,000
232,803,000
210,149,000
200,335,000
191,959,000
198,498,000
205,611,000
199,052,000
195,228,000
181,380,000
176,298,000
183,083,000
183,091,000
186,547,000
178,372,000
177,778,000
182,290,000
182,714,000
189,695,000
189,168,000
190,474,000
185,257,000
175,454,000
176,538,000
161,821,000
156,960,000
163,628,000
144,355,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.